N
Google TrendANNA BONDAR (200+) — October 11, 2026: Lilli Tagger vs Nikola Bartunkova: Set 1 Winner Prediction Market
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:anna bondar200+natanael cano100+green card500+power outage near me10000+india2000+sony playstation1000+loki100+hubert hurkacz200+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Barth Syndrome Treatment" (30 stories)

Top Headline Story

First patient receives Forzinity in Mighty Therapeutics’ Phase IV study
Lead StoryClinical Trials Arenageneral
Jul 9

First patient receives Forzinity in Mighty Therapeutics’ Phase IV study

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxQQUlwaldxbS0yb3gtMUxxU1ItUW1rOTFtZkxNcXhhRVFuSmJvZXhBRnV0X1hJMUxjTWM3V1NXTUF1SGJOdWRBWWluejMwTmNhUjdIVk15SF9PVnNvTHA4OUlmM01wUUpMckxGSkthTG9IQ0NNVUlJNmdET1N4ZXlUdjh6bG04eVVyaVJYdkZYWW1FajJfT1E?oc=5" target="_blank">First patient receives Forzinity in Mighty Therapeutics’ Phase IV study</a>  <font color="#6f6f6f">Clinical Trials Arena</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
200+23m ago

anna bondar

October 11, 2026: Lilli Tagger vs Nikola Bartunkova: Set 1 Winner Prediction Market

Filter stories
100+23m ago

natanael cano

Padres de Natanael Cano rompen el silencio tras retiro del cantante: "Es por el bien de nuestro hijo"

Filter stories
500+33m ago

green card

Vance says Microsoft replaced laid-off workers with foreign hires. Here’s what the visa data shows

Filter stories
10000+33m ago

power outage near me

LIVE | Atlanta weather: Power outages, tree damage remain as storm threat moves east

Filter stories

Search Results for "Barth Syndrome Treatment"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
The Winding Road from Bench to FDA Approval for First Mitochondria-Targeting Drug
WCM Newsroomgeneral

The Winding Road from Bench to FDA Approval for First Mitochondria-Targeting Drug

<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxPLUxJMlZ5TkEteGY5VmVvakJnYWxmQnlzTTg3eFZwWUh5Zzd6Q1gyNHFtREt6dnFMMUtpWlZIV1RMbEt4T1dJMUg2U3JBVkpJOXlKNkVZQnFYWURmSXdDRHQtSzYxOVRBM0JLZU8tVnZhVFBPT3ZjVHRqSWt5RTl2NksySXhKeXZvVVJHVUduTzR5OGVkc1h2b01SeE95MzVHOVVvUFhlRmFaTGs0d2dBY3ZyeEhudHRlR01qRjNuMGJZS0E?oc=5" target="_blank">The Winding Road from Bench to FDA Approval for First Mitochondria-Targeting Drug</a>  <font color="#6f6f6f">WCM Newsroom</font>

Read Full StoryMore like this
Mighty Therapeutics Announces First Patient Dosed in Phase 4 Confirmatory Study of Elamipretide in Barth Syndrome
PR Newswireworld

Mighty Therapeutics Announces First Patient Dosed in Phase 4 Confirmatory Study of Elamipretide in Barth Syndrome

<a href="https://news.google.com/rss/articles/CBMi_gFBVV95cUxNaldWV0pTSzlGMk5XNzR5elRUMV80ZmQzdlZlV09SREU0Q3ZoSUlmVWV3QkFnVTE5UE1LYXpDbV9pY3A4ZGJ6Y3daY01aeEJwOGdJUVZNb1I2SmlYLUFzWG91cUFXRmNnM0M5QmZWaEF3d0F3UW13bWF4QnVSVF9zQnFvX2pzaXlrdHBUMTRYYjhhLTFzd2xrOGFiWEhLRnRUX0pnRndlMl80bjRUd2VvYVVzT29FUHh0TzUtTk1QZVJMUC1QX0RwclFob0RhVkNIR1AxQVJyTm9JV1FyZXdmR0gxV0FXT0VfM3dwVGNTR19PT2RqR2t3TnhRdGtfUQ?oc=5" target="_blank">Mighty Therapeutics Announces First Patient Dosed in Phase 4 Confirmatory Study of Elamipretide in Barth Syndrome</a>  <font color="#6f6f6f">PR Newswire</font>

Read Full StoryMore like this
Accelerated FDA Approval of Elamipretide (Forzinity) for Barth Syndrome: First Disease-Specific Therapy in Patients ≥30 kg
Vera Healthgeneral

Accelerated FDA Approval of Elamipretide (Forzinity) for Barth Syndrome: First Disease-Specific Therapy in Patients ≥30 kg

<a href="https://news.google.com/rss/articles/CBMiS0FVX3lxTFBVb1hTX0VaN29GcGJZRWpacnBBcUplYlBGclZ6MkJrZTlGU3Z2elhGUk1ZUXk4cnlnZ1VVUThodmYwaDhLYlB6dmhzRQ?oc=5" target="_blank">Accelerated FDA Approval of Elamipretide (Forzinity) for Barth Syndrome: First Disease-Specific Therapy in Patients ≥30 kg</a>  <font color="#6f6f6f">Vera Health</font>

Read Full StoryMore like this
Barth Syndrome Treatment Market Trends 2025–2034
Global Market Insights Inc.markets

Barth Syndrome Treatment Market Trends 2025–2034

<a href="https://news.google.com/rss/articles/CBMiggFBVV95cUxQN3VDOWdka09tUmFrMnhlX2s0a3FjSXBaQ3QzNGVYeHVxRWpZaGlnbjEwNFJLQUZ2LU1BZUt5S2Iwc0JKUjZ0QUtSU0xXWFBURWJyLS1kcjN4WnhMN21PcnFyRFVBTkF1Xy0xS2NaWDdEOXVzYXcxeDQ0WGp4RnZnS1Vn?oc=5" target="_blank">Barth Syndrome Treatment Market Trends 2025–2034</a>  <font color="#6f6f6f">Global Market Insights Inc.</font>

Read Full StoryMore like this
EXCLUSIVE: US FDA cleared pricey rare disease drug over reviewer objections
Reutersgeneral

EXCLUSIVE: US FDA cleared pricey rare disease drug over reviewer objections

<a href="https://news.google.com/rss/articles/CBMi0gFBVV95cUxPSGlISjJBNUItc3RIOHBxSTZoOGxreXNwWGlJQlh6VmlGYmctbi1yLW5FS1otRnpFY1lxTFRnWVJ5RVdJeXo3eFRlSm50NWtQbEZwZktxeEpQVmNKRjlrYlNBeWZNSFpKejk2RkdrN1RWM3NaTi13ZDVXcXlPTnowS3FZR2RSREZQdHg4WWtOYkd2WVZPalRZWE5lSHNxR09pTzFYX0oxSlpTWmtLdlRvNTZxNUE0ZWxVYmduT2EtMExwU0I0bEwzVkxwSjNzYlpleFE?oc=5" target="_blank">EXCLUSIVE: US FDA cleared pricey rare disease drug over reviewer objections</a>  <font color="#6f6f6f">Reuters</font>

Read Full StoryMore like this
FDA Overruled Reviewers in Approving Stealth’s Barth Syndrome Treatment
BioSpacegeneral

FDA Overruled Reviewers in Approving Stealth’s Barth Syndrome Treatment

<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxOOUJ0SHdWZ0hmWWZIX3h4SXM2N05RSU83RFNxSUhid3JOeEVhcGpqSXMyR3RLelE3LVVzenlXU0pHZ0hTZGVkOGdSNWRueW9naURJdnpJNDQ2OTNac2dBTkNTN21la2VsN19fcDBRM05STXlrRExESVJlSS0xV0F2R2t5R1lkdHBmbGFxUFp6TG9oSWM3NlpzbDd0enBCR2M3ZzZtSQ?oc=5" target="_blank">FDA Overruled Reviewers in Approving Stealth’s Barth Syndrome Treatment</a>  <font color="#6f6f6f">BioSpace</font>

Read Full StoryMore like this
Some reviewers opposed FDA's approval of new drug for life-threatening disease
Cardiovascular Businessgeneral

Some reviewers opposed FDA's approval of new drug for life-threatening disease

<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxNcWZIMWJ4aHphSmt1aFpDcHBtZjlVY2ljMzAyVGdVUGVSTUEyQ3NleUxBSFhEc2RURWZ6aU1ta0F6NkVUYXZhRkVNWHpZbFVxV3J3dHhKSVJncTFWS2N5RkkwNk5zY2VZSW1tNmpvVWNiVTNpVE1kUzNwWEtCUWFHd24wRjJsaEhvZGw3XzZEZzB2N2xEY1lSRHRCRnJRNlllRE5qaUV0UzI1cDlxNlJ4dV91bkl4aHdZWWRFOVFFZWxsT1IwcUEtMkJ3VV9Kcm04?oc=5" target="_blank">Some reviewers opposed FDA's approval of new drug for life-threatening disease</a>  <font color="#6f6f6f">Cardiovascular Business</font>

Read Full StoryMore like this
Following tireless advocacy, Carter celebrates FDA approval for Barth syndrome treatment
U.S. Representative Buddy Carter (.gov)general

Following tireless advocacy, Carter celebrates FDA approval for Barth syndrome treatment

<a href="https://news.google.com/rss/articles/CBMie0FVX3lxTE5lTVlXN1ZpLVVBanFyNGp5S3RMUkNfaXV6RGctbGZkVzNGV3NXUERDWW1paVA1M3NPUTJJUXFiUFo0ZTdlRHZNYTdNdGtZckNjeTZPN1lKbE9KcW0yeG1KWW43dTRvel9qNlhnT1BuOHFmUjR6QnowbV93VQ?oc=5" target="_blank">Following tireless advocacy, Carter celebrates FDA approval for Barth syndrome treatment</a>  <font color="#6f6f6f">U.S. Representative Buddy Carter (.gov)</font>

Read Full StoryMore like this
AL Champion: Doctor and baby bond over ultra-rare diagnosis
WBMAgeneral

AL Champion: Doctor and baby bond over ultra-rare diagnosis

<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxQT2REVHVCWnA3bXNqdXNTelJlX3VLUzRrS21CUk14NV9NTzY1OTBHUktESzA0cTYxbjJqOENRWUhqelo1TURuWkhFLVhNX0pxYUdMZTlOX0pLTDVHYzRRcmxWWVk0UnlPbmtBSW9XQVZHdlBySzRSb2RMS2NjNDVIUkFQdUUyNzNqTzJRN1ZVQ1R3R3czTE9vbkUyWEM4SXdzUXpF?oc=5" target="_blank">AL Champion: Doctor and baby bond over ultra-rare diagnosis</a>  <font color="#6f6f6f">WBMA</font>

Read Full StoryMore like this
Stealth BioTherapeutics removes cloak to become Mighty
Fierce Pharmageneral

Stealth BioTherapeutics removes cloak to become Mighty

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxQTE5pWTJ6M1ZZR1ljNW9mSjJZMXoyRFN4UjNSNkttTEJ4QzU0YWVBQVNmQ2NaWVdFUi11X1E4cWp3a0hmS2VzVTZSMEJWcHRqZXJQMFNyaUZRYV8ySjN0N3Z0a0dPbXF3U3NjU2s1ZkN0ckFrdFhSQmZCU3ROTVZneGh0SGI0YnhPSC01N1ZnRDNxRUl2?oc=5" target="_blank">Stealth BioTherapeutics removes cloak to become Mighty</a>  <font color="#6f6f6f">Fierce Pharma</font>

Read Full StoryMore like this
FDA approves drug for treatment of rare mitochondrial disorder
Johns Hopkins Universitygeneral

FDA approves drug for treatment of rare mitochondrial disorder

<a href="https://news.google.com/rss/articles/CBMieEFVX3lxTE5PWHBHZHBaQkhtMkZpLWI0R3MwSF8yeWQ0cU1DbzNkWHlVQlRqb2hGT2NCYmVQZ285aWlpbUtLWmEzby1mVmJMYVM5Wk1zbWVOTEM2R3VKOHFGU1FpbFNfdkVHbi1jVVlXajJZNENaVnFPMUp2OEZkRA?oc=5" target="_blank">FDA approves drug for treatment of rare mitochondrial disorder</a>  <font color="#6f6f6f">Johns Hopkins University</font>

Read Full StoryMore like this
FDA Grants Accelerated Approval to Elamipretide, First Treatment for Barth Syndrome
Pharmacy Timesgeneral

FDA Grants Accelerated Approval to Elamipretide, First Treatment for Barth Syndrome

<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxQcnk4TU1xLWY4bGVjVC1abFFwZm80N2pJUHZsTF9QMlFWeXVJMEpoNmFPaVVMUG9KWFgxdzBORmFaRHNTbGY5UXZpTVBNTmUwVzZqS0tnb1VQZnJpZ09QMGhHNVVWd2ZSOHVTOThFZnpwV1VnMFZta1N5M3BqODRWVmpicnN1Wk5ObWxCcW9SYTBuYnpWdUVTbXl3Z29wdDdaak16RlNydHFFWmN6Q3ZlLUhBaGZrS1lV?oc=5" target="_blank">FDA Grants Accelerated Approval to Elamipretide, First Treatment for Barth Syndrome</a>  <font color="#6f6f6f">Pharmacy Times</font>

Read Full StoryMore like this
Orland Park baby's treatment for rare genetic disease Barth Syndrome granted accelerated approval by Food and Drug Administration
ABC7 Chicagogeneral

Orland Park baby's treatment for rare genetic disease Barth Syndrome granted accelerated approval by Food and Drug Administration

<a href="https://news.google.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?oc=5" target="_blank">Orland Park baby's treatment for rare genetic disease Barth Syndrome granted accelerated approval by Food and Drug Administration</a>  <font color="#6f6f6f">ABC7 Chicago</font>

Read Full StoryMore like this
FDA approves ultra-rare disease drug that became a symbol of uncertainty over regulatory standards
STATtech

FDA approves ultra-rare disease drug that became a symbol of uncertainty over regulatory standards

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxPWHJ4ZEU3TUxqNlVJbzdDRWwteUlEMC1CblBPZ1JZVEE4aFdJNl90SzRTOHlITWx5WWZfOXN1X1hRMFhsMEdUVll1ZVF2QnBlaklsU1h6aFA4NnJNY3R6YnFPY1ljNUtsWXNiWUlKSTdzdU9mRlVFRDhDNFpDai00djhDVDhRRzljN3NMT0ZpcDFJbVFYMHExOU9xV0lEQVhwTnFOZm1rYjlVOTNU?oc=5" target="_blank">FDA approves ultra-rare disease drug that became a symbol of uncertainty over regulatory standards</a>  <font color="#6f6f6f">STAT</font>

Read Full StoryMore like this
Stealth Bio’s Forzinity finally approved as first Barth syndrome therapy
Pharmaceutical Technologygeneral

Stealth Bio’s Forzinity finally approved as first Barth syndrome therapy

<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxPRDl1WGstWk1OOVlrT0lNeU5hNGF2SjJSMDUtT0ZEckhDaWdNQk1VWVNnQlFqcno3NUY3RkJLdHVnQW9ybEdZU1FTM1lEeGJHZHZmMHItZmM2NzZEQXJjWFNyc3pveUExcVNzd1V5Y1BHenZsZ185dy1TbFR5dWJCR3hxSDFyT3lyWlhDd09UUVFndGhWbzN2SzRoYzhrallOSXFnWExQcC1RYXV2cU1rVnA4enJLVTdMdWFn?oc=5" target="_blank">Stealth Bio’s Forzinity finally approved as first Barth syndrome therapy</a>  <font color="#6f6f6f">Pharmaceutical Technology</font>

Read Full StoryMore like this
Stealth BioTherapeutics to Present Updates on Elamipretide in Barth Syndrome and POLG Disease at Euromit 2026
PR Newswiregeneral

Stealth BioTherapeutics to Present Updates on Elamipretide in Barth Syndrome and POLG Disease at Euromit 2026

<a href="https://news.google.com/rss/articles/CBMi-AFBVV95cUxNN0JoS19qa1pMQTFjQlJTb1JEZDVpWElkNTJFUnliLTZQcDU0dEk3cG5rSGsyejItMy12TDl0SkVqLWVhYWJacmQwYXAxSDdoYS0xQl9rbXdQcDgyZW1XLUc1VnVaX3R3MHlKbDIwTUowMThBR3dNN1dFNVV0V3plaVo2YzVQakcwVW5rbGp0YUtoMm14OW5EbVdmcHJYQmkzMFpFNDUzTmlIbm5yaVRGOG5BbGhXR0FicVZycDNoeWNXb1YxdC1nUnB4a0thMVBxNmNKclVabzVDYzJUTURBMTMyMjg2NFozX3hkLVBqYUpGWVUxN3RVag?oc=5" target="_blank">Stealth BioTherapeutics to Present Updates on Elamipretide in Barth Syndrome and POLG Disease at Euromit 2026</a>  <font color="#6f6f6f">PR Newswire</font>

Read Full StoryMore like this
FORZINITY (elamipretide) for Muscle Strength in Barth syndrome, USA
Clinical Trials Arenageneral

FORZINITY (elamipretide) for Muscle Strength in Barth syndrome, USA

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxPLVl6VHZVVWtvQmhfQTlodXNLSXNvelR0NDBZRDFJc1hrcERfQ2dYXzNFNlJCMjJJRmlZMXFhemQySzlZajd1c0I0U1F4VWVpdU11SWtVSEhCVm54QUR3TjQ0d04xTDZvT2xTRHR1SnJIX252ZWE2eWFRR3BMZUtGd19ORXVmeHVIa1llSkVaR3NBNnhocjJTTENOUjQ0ZzRpWFh6MmhJTDRVdW1ZOTJv?oc=5" target="_blank">FORZINITY (elamipretide) for Muscle Strength in Barth syndrome, USA</a>  <font color="#6f6f6f">Clinical Trials Arena</font>

Read Full StoryMore like this
Stealth BioTherapeutics Provides Commercial Launch Update and Pipeline Progress Across Mitochondrial Disease Portfolio
BioSpaceworld

Stealth BioTherapeutics Provides Commercial Launch Update and Pipeline Progress Across Mitochondrial Disease Portfolio

<a href="https://news.google.com/rss/articles/CBMi7wFBVV95cUxOX19BUzlydkpEeFR4UTlwS3J0TWxWcnZTZU8xcnh4Z1FyVFdzQnAteUFDNW52dXU0OEcyWHFmNGJUcG55N1h1VDlkUjM3U0x6M0xwbDZfSF9tNWlBU29Qa0ktaWl4cFZEdG5MNU9xZUg5SmpVdmUxMWFXVlh3SXpxbjFtSmpfeHpKT05fQnNfbG9oWUF6YmtyNTZ4dWRyXzRFS2hxS01MUUtRTXZmS0JNWUo1Rm1lS3Zrb0RUNEUwRVVUUTNUeVFiQnV4Vjl5TWV5Y3ZkZW1YS1hwVUd2djdVTUgwcUF4SmgwTmFLdUVjNA?oc=5" target="_blank">Stealth BioTherapeutics Provides Commercial Launch Update and Pipeline Progress Across Mitochondrial Disease Portfolio</a>  <font color="#6f6f6f">BioSpace</font>

Read Full StoryMore like this
Stealth Wins Expedited FDA Nod for First-Ever Barth Syndrome Treatment
BioSpacegeneral

Stealth Wins Expedited FDA Nod for First-Ever Barth Syndrome Treatment

<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxQOXR4TUI3cTRTb1ZMZy1BUkpLelIxR2hDZ0pEUkNPXzY1SVVjUkl6dWloM0FwWjFJbjFnSFFwVzJldjRQVUV2VTRIMnhsVUdudlBXSzNJQXVWb2ZyWFBBTWhETTgwX0h4c0ZxbFFsSTdFOWFSTFNCUWdYb3BRREFhYW5iemxDUDVFWnM2M1g0Qno5WmxBa3A1emN2aV9iR0l1QlBMSU05UjJTTG1WU2NLSU53?oc=5" target="_blank">Stealth Wins Expedited FDA Nod for First-Ever Barth Syndrome Treatment</a>  <font color="#6f6f6f">BioSpace</font>

Read Full StoryMore like this
FDA rejects Stealth Bio’s Barth syndrome treatment after 16.5-month review
Pharmaceutical Technologygeneral

FDA rejects Stealth Bio’s Barth syndrome treatment after 16.5-month review

<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxQNEFLNy1EWVJ3TW9wd216UFB3MWRLZ2UydUtHOThWcmZGa2pmbjVxWHZsX0t2b3FtY3F2V2FJLXVpV1g3WXpEckJPcVNWclQwckhYWjRXcWM5TzBnYlUxVFlXWk1aa19fRHdfN21YRTVYWUdQbEtKc1RWR1F1aUk5OVRKdEw0TkJjMU9oTGRFb09NWUxKMGFuQ0hmNkZ1MkdITE95YUNBMkdkMGxJRmYwVml4OUExdHhJa3lnQi1n?oc=5" target="_blank">FDA rejects Stealth Bio’s Barth syndrome treatment after 16.5-month review</a>  <font color="#6f6f6f">Pharmaceutical Technology</font>

Read Full StoryMore like this
SS-31 treatment ameliorates cardiac mitochondrial morphology and defective mitophagy in a murine model of Barth syndrome
Naturegeneral

SS-31 treatment ameliorates cardiac mitochondrial morphology and defective mitophagy in a murine model of Barth syndrome

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBscjhwb1VsUDVjcHVZc0Ytdm5tX2dsWXhqcldyVFB6cV9rTnJSWlhUNGxybm10Ukx2bldiSGFCWTA2YzlOdUluWEVGVkJ6YVJOOTBVZ3hNWW9uSTlTaW1N?oc=5" target="_blank">SS-31 treatment ameliorates cardiac mitochondrial morphology and defective mitophagy in a murine model of Barth syndrome</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
FDA grants accelerated approval for first treatment for Barth syndrome
Medical Xpressgeneral

FDA grants accelerated approval for first treatment for Barth syndrome

<a href="https://news.google.com/rss/articles/CBMihgFBVV95cUxPRjhveTFtT2s3clhGOWlFOGdfdXBKaTZLODFoRlpPenZfVTVPV1dIVS1hRHdweWozcE83b2lBcl9Da0gzUmJJbjNBYmdsSF9IY1o4cG1yWlV2cGxTcHc1T1dHS21OaHJQdml1czhnSlRkUl9LVC1FcURDTGhKVmNuajJmRTg3QQ?oc=5" target="_blank">FDA grants accelerated approval for first treatment for Barth syndrome</a>  <font color="#6f6f6f">Medical Xpress</font>

Read Full StoryMore like this
Stealth BioTherapeutics Announces PDUFA Action Date Extension for Elamipretide to Treat Patients with Barth Syndrome
PR Newswireworld

Stealth BioTherapeutics Announces PDUFA Action Date Extension for Elamipretide to Treat Patients with Barth Syndrome

<a href="https://news.google.com/rss/articles/CBMiggJBVV95cUxQREtRdlhTTlhrOXdGQ0tFNXBFbVhuclEzZnhQR1g0aW1yUUo3d3UtTWJzdXBkNjNSVXluRDVaTGRMT2ItRmlYT3VBczJ2WVRYMzEzVnMzd25wOF9FbnhPRlhvRFhVWVdjdHZvaHcwZkxwNFMwZzFFVWh4UFY1aXF6ZzRJRi1nc3BHajZocmExMTM4VllLeF93czdxVVJoeW01MjFHUHdnLUlGQ3lwS09vYlNGWlZhU0pkT2ZBRk92eFlibXA2ZjZhMEdIeHowV1pMeG5TRDZ0SjEzQTV2ZlpWdE1kbkRJaTdYZkdZYjdpeEhBOUtYMmhBUzl2aW4wUXh0MlE?oc=5" target="_blank">Stealth BioTherapeutics Announces PDUFA Action Date Extension for Elamipretide to Treat Patients with Barth Syndrome</a>  <font color="#6f6f6f">PR Newswire</font>

Read Full StoryMore like this
Orland Park family campaigns for Food and Drug Administration over approval of drug to treat Barth syndrome, rare genetic disease
ABC7 Chicagotech

Orland Park family campaigns for Food and Drug Administration over approval of drug to treat Barth syndrome, rare genetic disease

<a href="https://news.google.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?oc=5" target="_blank">Orland Park family campaigns for Food and Drug Administration over approval of drug to treat Barth syndrome, rare genetic disease</a>  <font color="#6f6f6f">ABC7 Chicago</font>

Read Full StoryMore like this
After lengthy review, FDA snubs Stealth's Barth syndrome therapy
FirstWord Pharmageneral

After lengthy review, FDA snubs Stealth's Barth syndrome therapy

<a href="https://news.google.com/rss/articles/CBMiU0FVX3lxTFB5Q0pJdzRCb2g3SVpYVi1PdEltNG5JcXFWNDhmOUFkQWp0dlcxRTJ1ZFJtRnVDXy1FMVA3VmVndEsyU2FpX2JiSmNHU0RuUkgyUnE0?oc=5" target="_blank">After lengthy review, FDA snubs Stealth's Barth syndrome therapy</a>  <font color="#6f6f6f">FirstWord Pharma</font>

Read Full StoryMore like this
FDA clears first Barth syndrome drug amid scrutiny of rare disease stance
BioPharma Divegeneral

FDA clears first Barth syndrome drug amid scrutiny of rare disease stance

<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxPRjhZcm5vQXNSaW5tckxxS3JxTnRQLTRaWjZuQlZOZ3R2RkVYdGlqOUpzYVV1alRwc2VkdjJNU0w5R0hGVUdIZlhYaVBSTF94OXpwV0xrVExDSllKRWVDZUJ1OUd3aGx5aDFkVEY2U24wRlhBRUhvRVJTcEJWX2F6dko4UUNFZFNQTnVVT3gzRWg3ZVd4NDJPQUhwWXBBV25POWZnYjA4QV9fTmhNaHE0NWpQMnFUbmla?oc=5" target="_blank">FDA clears first Barth syndrome drug amid scrutiny of rare disease stance</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
First-ever approval for Barth Syndrome treatment: what does this mean for ultra-rare disease therapeutics?
Labiotech.eugeneral

First-ever approval for Barth Syndrome treatment: what does this mean for ultra-rare disease therapeutics?

<a href="https://news.google.com/rss/articles/CBMiigFBVV95cUxPNGFlS0NkQkdtNGowaVRld0NHQUhNS240MDBvZlFZdWdPcWd1SXlzbzZhVnc2OEZueXR1NHdkdWtOa0xXSlhTRjREdGh0TUtQSUIwRmJ1R0F1MWlsRThIT29xQlZqR2xjdFFic3laQWJ6cFpjMDlUbFNYQjB4SFZDaFpORml3YXBaeVE?oc=5" target="_blank">First-ever approval for Barth Syndrome treatment: what does this mean for ultra-rare disease therapeutics?</a>  <font color="#6f6f6f">Labiotech.eu</font>

Read Full StoryMore like this
Rep. Clyde Celebrates FDA Approval for Treatment of Rare Mitochondrial Disease Impacting Hall County Family
House.govworld

Rep. Clyde Celebrates FDA Approval for Treatment of Rare Mitochondrial Disease Impacting Hall County Family

<a href="https://news.google.com/rss/articles/CBMickFVX3lxTFBXZlVkYjBMM0Z2SUplSUlkcXNPRWo2ZHJLZnB3NGk2YVZjYThaVnQ4LTlZZXdKWDRYMzJIUjBRUHhTN1ltaE1XeUhvUEhKMGU0eVhkSjVIakwzbVlZUE5ULXIySGRLTDJDMkpCTklSTmQ4Zw?oc=5" target="_blank">Rep. Clyde Celebrates FDA Approval for Treatment of Rare Mitochondrial Disease Impacting Hall County Family</a>  <font color="#6f6f6f">House.gov</font>

Read Full StoryMore like this
Previously Rejected Drug Approved as First Barth Syndrome Treatment
MedPage Todaygeneral

Previously Rejected Drug Approved as First Barth Syndrome Treatment

<a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE82YmpvT2VjS2phbnFMWVNycHNuT3VNeVBsQk9UemE0Sjc3cWZfQ0pkaTBkcHZudkNNSWZnQ1JPUjVtalVRS3RDenh2Q1YtZFhhRVoxcFdKQkRoSDQzcllfUTJKSVhUczJRMER6eExpeDZYNUU?oc=5" target="_blank">Previously Rejected Drug Approved as First Barth Syndrome Treatment</a>  <font color="#6f6f6f">MedPage Today</font>

Read Full StoryMore like this
"Barth Syndrome Treatment" — Live Google News Trends & Headlines